231 related articles for article (PubMed ID: 15571459)
1. Prevention of calcification in bioprosthetic heart valves: challenges and perspectives.
Simionescu DT
Expert Opin Biol Ther; 2004 Dec; 4(12):1971-85. PubMed ID: 15571459
[TBL] [Abstract][Full Text] [Related]
2. A versatile modification strategy for functional non-glutaraldehyde cross-linked bioprosthetic heart valves with enhanced anticoagulant, anticalcification and endothelialization properties.
Yu T; Pu H; Chen X; Kong Q; Chen C; Li G; Jiang Q; Wang Y
Acta Biomater; 2023 Apr; 160():45-58. PubMed ID: 36764592
[TBL] [Abstract][Full Text] [Related]
3. Porcine bioprosthetic heart valves: The next generation.
Manji RA; Menkis AH; Ekser B; Cooper DK
Am Heart J; 2012 Aug; 164(2):177-85. PubMed ID: 22877802
[TBL] [Abstract][Full Text] [Related]
4. Radical polymerization-crosslinking method for improving extracellular matrix stability in bioprosthetic heart valves with reduced potential for calcification and inflammatory response.
Guo G; Jin L; Jin W; Chen L; Lei Y; Wang Y
Acta Biomater; 2018 Dec; 82():44-55. PubMed ID: 30326277
[TBL] [Abstract][Full Text] [Related]
5. Prevention of bioprosthetic heart valve calcification: strategies and outcomes.
Bre LP; McCarthy R; Wang W
Curr Med Chem; 2014; 21(22):2553-64. PubMed ID: 24358975
[TBL] [Abstract][Full Text] [Related]
6. A synergistic strategy of dual-crosslinking and loading intelligent nanogels for enhancing anti-coagulation, pro-endothelialization and anti-calcification properties in bioprosthetic heart valves.
Hu M; Shi S; Peng X; Pu X; Yu X
Acta Biomater; 2023 Nov; 171():466-481. PubMed ID: 37793601
[TBL] [Abstract][Full Text] [Related]
7. Feasibility evaluation of a new pericardial bioprosthesis with dye mediated photo-oxidized bovine pericardial tissue.
Bianco RW; Phillips R; Mrachek J; Witson J
J Heart Valve Dis; 1996 May; 5(3):317-22. PubMed ID: 8793684
[TBL] [Abstract][Full Text] [Related]
8. Calcification of tissue heart valve substitutes: progress toward understanding and prevention.
Schoen FJ; Levy RJ
Ann Thorac Surg; 2005 Mar; 79(3):1072-80. PubMed ID: 15734452
[TBL] [Abstract][Full Text] [Related]
9. Noncalcific Mechanisms of Bioprosthetic Structural Valve Degeneration.
Marro M; Kossar AP; Xue Y; Frasca A; Levy RJ; Ferrari G
J Am Heart Assoc; 2021 Feb; 10(3):e018921. PubMed ID: 33494616
[TBL] [Abstract][Full Text] [Related]
10. Physiological variables involved in heart valve substitute calcification.
Lee CH
Expert Opin Biol Ther; 2009 Aug; 9(8):1031-42. PubMed ID: 19555314
[TBL] [Abstract][Full Text] [Related]
11. Increased cellular expression of matrix proteins that regulate mineralization is associated with calcification of native human and porcine xenograft bioprosthetic heart valves.
Srivatsa SS; Harrity PJ; Maercklein PB; Kleppe L; Veinot J; Edwards WD; Johnson CM; Fitzpatrick LA
J Clin Invest; 1997 Mar; 99(5):996-1009. PubMed ID: 9062358
[TBL] [Abstract][Full Text] [Related]
12. Neomycin fixation followed by ethanol pretreatment leads to reduced buckling and inhibition of calcification in bioprosthetic valves.
Raghavan D; Shah SR; Vyavahare NR
J Biomed Mater Res B Appl Biomater; 2010 Jan; 92(1):168-77. PubMed ID: 19810110
[TBL] [Abstract][Full Text] [Related]
13. Bioprosthetic heart valves: modes of failure.
Siddiqui RF; Abraham JR; Butany J
Histopathology; 2009 Aug; 55(2):135-44. PubMed ID: 19694820
[TBL] [Abstract][Full Text] [Related]
14. Bioprosthetic heart valve failure: pathology and pathogenesis.
Schoen FJ; Levy RJ
Cardiol Clin; 1984 Nov; 2(4):717-39. PubMed ID: 6400011
[TBL] [Abstract][Full Text] [Related]
15. Pathology of substitute heart valves: new concepts and developments.
Schoen FJ; Levy RJ
J Card Surg; 1994 Mar; 9(2 Suppl):222-7. PubMed ID: 8186572
[TBL] [Abstract][Full Text] [Related]
16. Heart valve replacement surgery: past, present and future.
Starr A; Fessler CL; Grunkemeier G; He GW
Clin Exp Pharmacol Physiol; 2002 Aug; 29(8):735-8. PubMed ID: 12100012
[TBL] [Abstract][Full Text] [Related]
17. In Search of the Ideal Valve: Optimizing Genetic Modifications to Prevent Bioprosthetic Degeneration.
Smood B; Hara H; Cleveland DC; Cooper DKC
Ann Thorac Surg; 2019 Aug; 108(2):624-635. PubMed ID: 30836101
[TBL] [Abstract][Full Text] [Related]
18. [Cellular Composition of Calcified Bioprosthetic Heart Valves].
Mukhamadiyarov RA; Rutkovskayal NV; Sidorova OD; Barbarash LS
Vestn Ross Akad Med Nauk; 2015; (6):662-8. PubMed ID: 27093793
[TBL] [Abstract][Full Text] [Related]
19. Prosthetic Heart Valve Thrombosis.
Dangas GD; Weitz JI; Giustino G; Makkar R; Mehran R
J Am Coll Cardiol; 2016 Dec; 68(24):2670-2689. PubMed ID: 27978952
[TBL] [Abstract][Full Text] [Related]
20. Zwitterionic hydrogel-coated heart valves with improved endothelialization and anti-calcification properties.
Luo Y; Huang S; Ma L
Mater Sci Eng C Mater Biol Appl; 2021 Sep; 128():112329. PubMed ID: 34474880
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
